Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Lowered to $778 at Truist Securities

May 18, 2026 5:21 AM
Truist Securities analyst Greg Renza lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $778.00 (from $796.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change